A new study just published on Feb 2011 in the journal of cancer makes a strong argument for applying hyperbaric oxygenation therapy (HBOT) for those patients who have had either surgery or radiation therapy for brain tumors. The study followed patients who had been treated with HBOT and there was a marked improvement in cognitive [...]
» Click Here to Read the full ArticleIntravenous Vitamin C Therapy Irrefutably Kills
Cancer Cells
Vitamin C is a well-known antioxidant that is integral for life. Research has shown that high blood levels of vitamin C (only achievable through IV form) has been found to be extremely destructive to cellular DNA, preferentially toxic to human cancer cell lines. Achieving blood levels of 200mg to 400 mg per dl were shown in one study to kill 100% of colon cancer cells in the laboratory. In addition to the scientific literature, many clinical trials and case studies have shown dramatic improvements with reduction of tumor markers and increase in survival time. The side effects are virtually NONE if correctly procedures are taken. Knowing the effectiveness of this cancer-killing agent and the virtual inexistence complications that occur, we feel that this treatment should be essential in all cancer therapy programs.
Laboratory experiments show that vitamin C will kill cancer cells while leaving normal cells unharmed. Normal cells have an enzyme which neutralizes vitamin C while cancer cells do not. To achieve high enough blood levels for this effect, 60 mg of IV C must be given over a period of one hour. Addition of lipoic acid (an antioxidant) enabled the researchers to achieve the same effect at a lower dose of vitamin C. Safety studies on IV vitamin C show no harmful effects at doses up to 50 grams per day.
Riordan N, Riordan H, Casiari J. Clinical and experimental experiences with intravenous vitamin C. J Orthomolecular Medicine. Special Issue. 15(4):201-13. 1999.
Vitamin C was shown in this study to induce self-destruction of cancer cells. Blood concentrations high enough to be effective were achieved with intravenous administration of vitamin C.
Casciari JJ, et al. Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. Br J Cancer. 2001 Jun 1;84(11):1544-50.
Vitamin C at low doses is an antioxidant and can block the effectiveness of chemotherapy. However, intravenous vitamin C at high doses will enhance chemotherapy and induce cancer cell death. The type of vitamin C and the type of cell affect the outcome.
Sakagami H, et al. Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol (Noisy-le-grand). 2000 Feb;46(1):129-43.
The Linus Pauling Institute recommends that any patient receiving intravenous vitamin C therapy for cancer treatment also receive oral dosage of vitamin C as maintenance therapy. This should be continued indefinitely after the intravenous therapy. Cameron E. Protocol for the use of vitamin C in the treatment of cancer. Med Hypotheses. 1991 Nov;36(3):190-4
